• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pharma companies give $37 million in aid to Japan

Pharma companies give $37 million in aid to Japan

March 23, 2011
CenterWatch Staff

As Japan struggles to recover from earthquake and tsunami destruction, drugmakers have been helping with cash, medicines and supplies, according to Pharma Times.

The International Federation of Pharmaceutical Manufacturers & Associations reports the total cash value of assistance provided so far by its members already is $37 million. The majority of the donations are in cash, "as this form of aid is the most helpful according to non-governmental organization partners specialized in disaster relief."

Companies and their associated philanthropic foundations that have made donations  include Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche and Sanofi-aventis.   Japanese firms Astellas, Daiichi Sankyo, Eisai and Takeda are also contributing. The companies are using "long-established partnerships with expert medical and disaster relief organizations," IFPMA noted, including the Red Cross, Save the Children, AmeriCares, Direct Relief International and the International Medical Corps.

Eduardo Pisani, director-general of IFPMA, said, as “countless Japanese people are facing the daunting task of rebuilding their lives and cities... they are dealing with the immediate challenges of homelessness, hunger, contamination of drinking water with potentially life-threatening infectious diseases and coping with possible psychological health problems." Drugmakers "understand these threats and the difficulty of responding to them for the Japanese government and aid organizations."

The Japan Pharmaceutical Manufacturers Association said it has sent 10 tons of drugs such as antibiotics, diabetes treatments and antihypertensives to Sendai and Hanamaki Airport via U.S. military aircraft.  Most pharmaceutical companies operating in the country have reported their employees safe and they do not expect major disruption to their operations.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing